Low prevalence of cyp51A key mutations in Aspergillus fumigatus in Germany in primary clinical samples (blood, BAL, biopsies, CSF) and isolates of immunocompromised patients

Authors :: Spiess, B.
Postina, P.
Reinwald, M.
Seifarth, W.
Will, S.
Cornely, O.A.
Vehreschild, M.J.G.T.
Rath, P.-M.
Lauten, M.
Hofmann, W.-K.
Buchheidt, D.
Source :: Frühjahrstagung der Sektion Antimykotische Chemotherapie 2013; 20130412-20130413; Bonn; DOC13sac05 /20130618/
Publication Year :: 2013
Publisher :: German Medical Science GMS Publishing House; Düsseldorf, 2013.
Abstract: Objectives: As the incidence of azole resistance in Aspergillus fumigatus is rising and the diagnosis of invasive aspergillosis (IA) in immunocompromised patients is rarely based on positive culture yield in this group of patients, we established the molecular detection of azole resistance directly [for full text, please go to the a.m. URL]<br />Frühjahrstagung der Sektion Antimykotische Chemotherapie 2013

Language :: English
Database :: OpenAIRE
Journal :: Frühjahrstagung der Sektion Antimykotische Chemotherapie 2013; 20130412-20130413; Bonn; DOC13sac05 /20130618/
Accession number :: edsair.doi.dedup.....2345c4ab19c518bf076db65e48793066
Full Text :: https://doi.org/10.3205/13sac05

Full Text Access

Tools